Cytek Biosciences (CTKB) Asset Writedowns and Impairment (2020 - 2026)
Cytek Biosciences posted quarterly Asset Writedowns and Impairment of $193000.0 for Q1 2026, down 37.94% on a QoQ basis from $311000.0 in Q4 2025.
Cytek Biosciences (CTKB) has 7 years of Asset Writedowns and Impairment data on file, last reported at $193000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $193000.0; the trailing twelve-month figure through Mar 2026 stood at $606000.0 (up 162.09% YoY), and the FY2025 full-year result was $413000.0, up 745.31% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $193000.0, down from $311000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $912000.0 in Q1 2024 and bottomed at -$1.1 million in Q3 2024.
- The 5-year median for Asset Writedowns and Impairment is $125000.0 (2024), against an average of $104466.7.
- The widest annual swing landed in 2023, when Asset Writedowns and Impairment tumbled 279.93%; it then soared 3355.56% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $294000.0 in 2022, then sank by 279.93% to -$529000.0 in 2023, then surged by 101.7% to $9000.0 in 2024, then jumped by 3355.56% to $311000.0 in 2025, then tumbled by 37.94% to $193000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $193000.0 (Q1 2026), $311000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytek Biosciences | - | - | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 311,000.00 |
| Dec 31, 2025 | 311,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -1.11 Mn |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Mar 31, 2024 | 912,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Dec 31, 2023 | -529,000.00 |
| Sep 30, 2023 | 784,000.00 |
| Sep 30, 2023 | 784,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 213,000.00 |
| Jun 30, 2022 | 213,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 155,000.00 |
| Dec 31, 2021 | 155,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Jun 30, 2021 | -58,000.00 |
| Jun 30, 2021 | -58,000.00 |
| Mar 31, 2021 | 321,000.00 |
| Mar 31, 2021 | 321,000.00 |
| Dec 31, 2020 | 370,000.00 |
| Dec 31, 2020 | 370,000.00 |
| Sep 30, 2020 | 402,000.00 |
| Sep 30, 2020 | 402,000.00 |